105 related articles for article (PubMed ID: 515769)
41. Ionic dialysance: a new valid parameter for quantification of dialysis efficiency in acute renal failure?
Ridel C; Osman D; Mercadal L; Anguel N; Petitclerc T; Richard C; Vinsonneau C
Intensive Care Med; 2007 Mar; 33(3):460-5. PubMed ID: 17235509
[TBL] [Abstract][Full Text] [Related]
42. Boron diffusion across the dialysis membrane during hemodialysis.
Usuda K; Kono K; Nishiura K; Miyata K; Nishiura H; Saito M; Goto E; Nakaya H
Miner Electrolyte Metab; 1997; 23(2):100-4. PubMed ID: 9252976
[TBL] [Abstract][Full Text] [Related]
43. Relationship between serum intact parathyroid hormone and pruritus in hemodialysis patients.
Makhlough A; Emadi N; Sedighi O; Khademloo M; Bicmohamadi AR
Iran J Kidney Dis; 2013 Jan; 7(1):42-6. PubMed ID: 23314141
[TBL] [Abstract][Full Text] [Related]
44. Treatment time, chronic inflammation, and hemodynamic stability: the overlooked parameters in hemodialysis quantification.
Zsom L; Zsom M; Fulop T; Flessner MF
Semin Dial; 2008; 21(5):395-400. PubMed ID: 18945325
[TBL] [Abstract][Full Text] [Related]
45. Effect of hemodialysis on the pharmacokinetics of theophylline in chronic renal failure.
Kradjan WA; Martin TR; Delaney CJ; Blair AD; Cutler RE
Nephron; 1982; 32(1):40-4. PubMed ID: 7177275
[TBL] [Abstract][Full Text] [Related]
46. Glomerulopressin in end-stage renal disease. Effect of hemodialysis.
Zhou XJ; Vaziri ND; Kaupke CJ
ASAIO Trans; 1991; 37(3):M235-6. PubMed ID: 1751125
[TBL] [Abstract][Full Text] [Related]
47. Relationship between urea clearance and ionic dialysance determined using a single-step conductivity profile.
Di Filippo S; Pozzoni P; Manzoni C; Andrulli S; Pontoriero G; Locatelli F
Kidney Int; 2005 Nov; 68(5):2389-95. PubMed ID: 16221245
[TBL] [Abstract][Full Text] [Related]
48. Low-dose doxepin for treatment of pruritus in patients on hemodialysis.
Pour-Reza-Gholi F; Nasrollahi A; Firouzan A; Nasli Esfahani E; Farrokhi F
Iran J Kidney Dis; 2007 Jul; 1(1):34-7. PubMed ID: 19357442
[TBL] [Abstract][Full Text] [Related]
49. Treatment of Gabapentin Toxicity With Peritoneal Dialysis: Assessment of Gabapentin Clearance.
Ibrahim H; Oman Z; Schuelke M; Edwards JC
Am J Kidney Dis; 2017 Dec; 70(6):878-880. PubMed ID: 28676198
[TBL] [Abstract][Full Text] [Related]
50. Pruritus in dialysis patients treated with parenteral lidocaine.
Tapia L; Cheigh JS; David DS; Sullivan JF; Saal S; Reidenberg MM; Stenzel KH; Rubin AL
N Engl J Med; 1977 Feb; 296(5):261-2. PubMed ID: 831109
[No Abstract] [Full Text] [Related]
51. Zinc sulfate for relief of pruritus in patients on maintenance hemodialysis.
Najafabadi MM; Faghihi G; Emami A; Monghad M; Moeenzadeh F; Sharif N; Davarpanah Jazi AH
Ther Apher Dial; 2012 Apr; 16(2):142-5. PubMed ID: 22458392
[TBL] [Abstract][Full Text] [Related]
52. A randomized controlled trial of high-permeability haemodialysis against conventional haemodialysis in the treatment of uraemic pruritus.
Chen ZJ; Cao G; Tang WX; Lv XY; Huang SM; Qin W; Ping F; Ye T
Clin Exp Dermatol; 2009 Aug; 34(6):679-83. PubMed ID: 19175617
[TBL] [Abstract][Full Text] [Related]
53. Understanding pruritis in dialysis patients.
Makari J; Cameron K; Battistella M
CANNT J; 2013; 23(1):19-23; quiz 24-5. PubMed ID: 23659030
[No Abstract] [Full Text] [Related]
54. Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD.
McKane W; Chandna SM; Tattersall JE; Greenwood RN; Farrington K
Kidney Int; 2002 Jan; 61(1):256-65. PubMed ID: 11786108
[TBL] [Abstract][Full Text] [Related]
55. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
Ifudu O; Feldman J; Friedman EA
N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
[TBL] [Abstract][Full Text] [Related]
56. Angiotensin Converting Enzyme Inhibitor Dialyzability and Outcomes in Older Patients Receiving Hemodialysis.
Weir MA; Fleet JL; Dixon SN; Jain AK; Oliver M; Wald R; McIntyre C; Garg AX
Blood Purif; 2015; 40(3):232-42. PubMed ID: 26382240
[TBL] [Abstract][Full Text] [Related]
57. Serum bile acids and pruritus in hemodialysis patients.
Mamianetti A; Tripodi V; Vescina C; Garrido D; Vizioli N; Carducci C; Agost Carreño C
Clin Nephrol; 2000 Mar; 53(3):194-8. PubMed ID: 10749298
[TBL] [Abstract][Full Text] [Related]
58. Gabapentin and uremic pruritus in hemodialysis patients.
Razeghi E; Eskandari D; Ganji MR; Meysamie AP; Togha M; Khashayar P
Ren Fail; 2009; 31(2):85-90. PubMed ID: 19212903
[TBL] [Abstract][Full Text] [Related]
59. Dialyzability of the antiepileptic drug zonisamide in patients undergoing hemodialysis.
Ijiri Y; Inoue T; Fukuda F; Suzuki K; Kobayashi T; Shibahara N; Takenaka H; Tanaka K
Epilepsia; 2004 Aug; 45(8):924-7. PubMed ID: 15270757
[TBL] [Abstract][Full Text] [Related]
60. [Beneficial effect of zinc supplementation on pruritus in hemodialysis patients with special reference to changes in serum histamine levels].
Sanada S; Kuze M; Yoshida O
Hinyokika Kiyo; 1987 Dec; 33(12):1955-60. PubMed ID: 3448919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
